MedPath

A Clinical Study Of Vardhaman Pippali Rasayan and Vidangadi Loha In Anaemia

Phase 2
Conditions
Health Condition 1: E611- Iron deficiency
Registration Number
CTRI/2022/11/047446
Lead Sponsor
Tilak Ayurved Mahavidyalaya Pune
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)The presence of symptoms of Pandu as described in classical Ayurvedic texts such as Panduta, Dourbalya, Shirshoola, Shwasa, Hridaspandan, Aruchi, Akshi koota shotha, Pindikoudveshthan, Bhrama, Rukshata, Gourava and Shrama.

2)Women of reproductive age group of 15-49 years

3)Patients having history of Hb% <12 g% (Female) , low mean corpuscular volume (MCV) ( <80 fl); serum iron <50 µg/dl, total iron binding capacity (TIBC) >360 µg/dl.

Exclusion Criteria

1)Patients having history of Haemoglobin <7 gm%

2)Patients suffering from haematological disorders such as sickle-cell anaemia and thalassemia are excluded.

3)Patients having history of systemic disorders such as uncontrolled hypertension, uncontrolled diabetes mellitus, AIDS, and cancer.

4)Pregnant females and lactating mothers.

5)Gynaecological diseases like Menorrhagia and Obstetric disorders leading to blood loss

6)Grishma and Sharad Ritu.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in PANDUTA, DOURBALYA, SHIRASHOOLA, SHWAS ,HRIDSPANDAN, ARUCHI, AKSHIKOOTA, SHOTH, PINDIKODWESHTAN, BHRAMA, RUKSHATA, GAURAVA, SHRAMA, Hb% ,RBC, MCV, MCH, MCHC and TIBCTimepoint: baseline,10th day, 21st day
Secondary Outcome Measures
NameTimeMethod
to study the adverse effects of Vardhaman Pippali rasayan, if anyTimepoint: 21 days
© Copyright 2025. All Rights Reserved by MedPath